GlaxoSmithKline/Adolor Entereg Resubmission Pushed Out To Third Quarter
Response to November “approvable” letter for postoperative ileus NDA will take an additional quarter following an FDA request for more data in the resubmission.
Response to November “approvable” letter for postoperative ileus NDA will take an additional quarter following an FDA request for more data in the resubmission.